Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

A. Lim · SciRah

Researcher profile · Semantic Scholar

A. Lim

Share profile

A. Lim — researcher profile on SciRah

h-index: 19
Works: 65
Citations: 2,561

Most-cited papers

PD‐1 Blockade with Cemiplimab in Advanced Cutaneous Squamous‐Cell Carcinoma
M. Migden, D. Rischin, C. Schmults, A. Guminski +33 more
2018New England Journal of Medicine1,193 citations Open access
Semantic Scholar
Neoadjuvant Cemiplimab for Stage II to IV Cutaneous Squamous-Cell Carcinoma
N. Gross, D. Miller, N. Khushalani, V. Divi +25 more
2022New England Journal of Medicine255 citations Open access
Semantic Scholar
Phase 2 study of cemiplimab in patients with metastatic cutaneous squamous cell carcinoma: primary analysis of fixed-dosing, long-term outcome of weight-based dosing
D. Rischin, M. Migden, A. Lim, C. Schmults +24 more
2020Journal for ImmunoTherapy of Cancer162 citations Open access
Semantic Scholar
Integrated analysis of a phase 2 study of cemiplimab in advanced cutaneous squamous cell carcinoma: extended follow-up of outcomes and quality of life analysis
D. Rischin, N. Khushalani, C. Schmults, A. Guminski +20 more
2021Journal for ImmunoTherapy of Cancer104 citations Open access
Semantic Scholar
Relationship between Epidermal Growth Factor Receptor Status, p16INK4A, and Outcome in Head and Neck Squamous Cell Carcinoma
R. Young, D. Rischin, R. Fisher, G. McArthur +6 more
2011Cancer Epidemiology, Biomarkers and Prevention91 citations Open access
Semantic Scholar
Differential mechanisms of CDKN2A (p16) alteration in oral tongue squamous cell carcinomas and correlation with patient outcome
A. Lim, H. Do, R. Young, Stephen Q. Wong +12 more
2014International Journal of Cancer70 citations
Semantic Scholar
Neoadjuvant cemiplimab and surgery for stage II-IV cutaneous squamous-cell carcinoma: follow-up and survival outcomes of a single-arm, multicentre, phase 2 study.
N. Gross, David Miller, N. Khushalani, V. Divi +23 more
2023The Lancet Oncology69 citations
Semantic Scholar
A comparative study of extracellular vesicle-associated and cell-free DNA and RNA for HPV detection in oropharyngeal squamous cell carcinoma
B. Nguyen, K. Meehan, M. Pereira, B. Mirzai +10 more
2020Scientific Reports51 citations Open access
Semantic Scholar
Prognostic significance of plasma osteopontin in patients with loco-regionally advanced head and neck squamous cell carcinoma treated on TROG 02.02 Phase III trial
A. Lim, D. Rischin, R. Fisher, Hongbin Cao +7 more
2011Clinical Cancer Research50 citations Open access
Semantic Scholar
BRAF Inhibition in BRAFV600E-Positive Anaplastic Thyroid Carcinoma.
A. Lim, G. Taylor, A. Fellowes, Laird B Cameron +6 more
2016The Journal of the National Comprehensive Cancer Network41 citations Open access
Semantic Scholar
Immunotherapy to Avoid Orbital Exenteration in Patients With Cutaneous Squamous Cell Carcinoma
Luke S. McLean, A. Lim, A. Webb, K. Cavanagh +5 more
2022Frontiers in Oncology33 citations Open access
Semantic Scholar
Phase II study of cemiplimab in patients (pts) with advanced cutaneous squamous cell carcinoma (CSCC): Longer follow-up.
D. Rischin, N. Khushalani, C. Schmults, A. Guminski +15 more
202033 citations
Semantic Scholar
A phase II study of induction carboplatin and gemcitabine followed by chemoradiotherapy for the treatment of locally advanced nasopharyngeal carcinoma.
A. Lim, J. Corry, M. Collins, L. Peters +6 more
2013Oral Oncology32 citations
Semantic Scholar
Frequency of fibroblast growth factor receptor 1 gene amplification in oral tongue squamous cell carcinomas and associations with clinical features and patient outcome.
R. Young, A. Lim, C. Angel, M. Collins +12 more
2013Oral Oncology30 citations
Semantic Scholar
Phase 2 study of cemiplimab, a human monoclonal anti-PD-1, in patients (pts) with metastatic cutaneous squamous cell carcinoma (mCSCC; Group 1): 12-month follow-up.
A. Guminski, A. Lim, N. Khushalani, C. Schmults +16 more
2019Journal of Clinical Oncology29 citations
Semantic Scholar
Characterization of the immune profile of oral tongue squamous cell carcinomas with advancing disease
K. Meehan, Connull Leslie, M. Lucas, Angela Jacques +11 more
2020Cancer Medicine24 citations Open access
Semantic Scholar
Immune checkpoint inhibitor therapy for advanced cutaneous squamous cell carcinoma in Australia: a retrospective real world cohort study
Luke S. McLean, A. Lim, M. Bressel, Jenny H Lee +15 more
2024Medical Journal of Australia23 citations Open access
Semantic Scholar
Quantitative methodology is critical for assessing DNA methylation and impacts on correlation with patient outcome
A. Lim, I. Candiloro, N. Wong, M. Collins +12 more
2014Clinical Epigenetics23 citations Open access
Semantic Scholar
Inducible T cell costimulatory (ICOS) receptor agonist, GSK3359609 (GSK609) alone and in combination with pembrolizumab (pembro): Preliminary results from INDUCE-1 expansion cohorts (EC) in head and neck squamous cell carcinoma (HNSCC)
D. Rischin, S. Groenland, A. Lim, J. Martin-Liberal +16 more
2019Annals of Oncology21 citations Open access
Semantic Scholar
FDG-PET/CT imaging for evaluating durable responses to immune check point inhibitors in patients with advanced cutaneous squamous cell carcinoma
Luke S. McLean, K. Cavanagh, R. Hicks, J. Callahan +4 more
2021Cancer Imaging17 citations Open access
Semantic Scholar
Updated analysis of the inducible T-cell co-stimulatory receptor (ICOS) agonist, GSK3359609 (GSK609), combination with pembrolizumab (PE) in patients (pts) with anti-PD-1/L1 treatment-naïve head and neck squamous cell carcinoma (HNSCC).
E. Angevin, S. Groenland, A. Lim, J. Martin-Liberal +16 more
202016 citations
Semantic Scholar
Assessment of perineural spread in advanced cutaneous squamous cell carcinomas treated with immunotherapy
K. Cavanagh, Luke S. McLean, A. Lim, Anthony Cardin +2 more
2024Cancer Imaging14 citations Open access
Semantic Scholar
The Current Treatment Landscape of Cutaneous Squamous Cell Carcinoma
Chia Chong, Michelle S. Y. Goh, S. Porceddu, D. Rischin +1 more
2022American Journal of Clinical Dermatology14 citations
Semantic Scholar
Immunotherapy for Anaplastic Thyroid Carcinoma.
A. Lim, B. Solomon
2020Journal of Clinical Oncology13 citations
Semantic Scholar
Prolonged remission in a patient with nasopharyngeal carcinoma with a solitary bone metastasis.
A. Lim, J. Corry, E. Lau, D. Rischin
2011Journal of Clinical Oncology13 citations
Semantic Scholar
Biology and Treatment Advances in Cutaneous Squamous Cell Carcinoma
A. Thai, A. Lim, B. Solomon, D. Rischin
2021Cancers12 citations Open access
Semantic Scholar
High response rate with extended dosing of cemiplimab in advanced cutaneous squamous cell carcinoma
D. Rischin, B. Hughes, N. Basset-Seguin, D. Schadendorf +23 more
2024Journal for ImmunoTherapy of Cancer11 citations Open access
Semantic Scholar
Delayed Response After Confirmed Progression (DR) and Other Unique Immunotherapy-Related Treatment Concepts in Cutaneous Squamous Cell Carcinoma
A. Lim, K. Cavanagh, R. Hicks, L. McLean +3 more
2021Frontiers in Oncology11 citations Open access
Semantic Scholar
Real-World Experience of Immune-Checkpoint Inhibitors in Older Patients with Advanced Cutaneous Squamous Cell Carcinoma
Luke S. McLean, A. Lim, M. Bressel, A. Thai +1 more
2024Drugs & Aging10 citations Open access
Semantic Scholar
Phase II study of 2 dosing regimens of cemiplimab, a human monoclonal anti–PD-1, in metastatic cutaneous squamous cell carcinoma (mCSCC)
D. Rischin, A. Lim, C. Schmults, N. Khushalani +15 more
2019Annals of Oncology10 citations Open access
Semantic Scholar
Genome-scale methylation assessment did not identify prognostic biomarkers in oral tongue carcinomas
A. Lim, N. Wong, R. Pidsley, E. Zotenko +5 more
2016Clinical Epigenetics10 citations Open access
Semantic Scholar
Correlation of Ataxia-Telangiectasia-Mutated (ATM) gene loss with outcome in head and neck squamous cell carcinoma.
A. Lim, R. Young, M. Collins, S. Fox +5 more
2012Oral Oncology10 citations
Semantic Scholar
Radiological, Pathological, and Surgical Outcomes with Neoadjuvant Cemiplimab for Stage II–IV Cutaneous Squamous Cell Carcinoma in the Deep Sequencing in Cutaneous Squamous Cell Carcinomas (DISCERN) Trial
A. Lim, B. Baker, Peter Lion, C. Angel +13 more
2025Cancers9 citations Open access
Semantic Scholar
Weekly cisplatin and radiotherapy for low risk, locoregionally advanced human papillomavirus–positive oropharyngeal squamous cell carcinoma
D. Urban, J. Corry, B. Solomon, A. Lim +7 more
2016Head and Neck9 citations
Semantic Scholar
Low-coverage whole-genome sequencing of extracellular vesicle-associated DNA in patients with metastatic cancer
B. Nguyen, N. Wong, T. Semple, M. Clark +6 more
2021Scientific Reports8 citations Open access
Semantic Scholar
Feasibility of 5-fluorouracil pharmacokinetic monitoring using the My-5FU PCM™ system in a quaternary oncology centre
M. Moloney, D. Faulkner, E. Link, D. Rischin +5 more
2018Cancer Chemotherapy and Pharmacology8 citations
Semantic Scholar
Characterising B cell expression and prognostic significance in human papillomavirus positive oropharyngeal cancer.
R. Young, C. Angel, M. Bressel, Angela Pizzolla +8 more
2024Oral Oncology5 citations
Semantic Scholar
Clinicopathological characteristics and clinical morbidity in high‐risk head and neck cutaneous squamous cell carcinoma patients in Western Australia
P. Grover, S. Flukes, Angela Jacques, S. Leedman +5 more
2021Internal medicine journal (Print)5 citations Open access
Semantic Scholar
1O Inducible T cell co-stimulatory (ICOS) receptor agonist, GSK3359609 (GSK609) alone and combination with pembrolizumab: Preliminary results from INDUCE-1 expansion cohorts in head and neck squamous cell carcinoma (HNSCC)
C. le Tourneau, D. Rischin, S. Groenland, A. Lim +16 more
2020Annals of Oncology5 citations Open access
Semantic Scholar
Primary analysis of phase 2 results for cemiplimab, a human monoclonal anti-PD-1, in patients with metastatic cutaneous squamous cell carcinoma (mCSCC).
D. Rischin, M. Migden, A. Chang, C. Chung +16 more
20185 citations
Semantic Scholar
A Retrospective Review and Comprehensive Tumour Profiling of Advanced Non-Melanomatous Cutaneous Spindle Cell Neoplasms Treated with Immune-Checkpoint Inhibitors
Luke S. McLean, A. Lim, C. Angel, R. Young +6 more
2024Cancers4 citations Open access
Semantic Scholar
Phase 2 Study of Cemiplimab in Patients with Advanced Cutaneous Squamous Cell Carcinoma (CSCC): Longer Follow-Up
D. Rischin, N. Khushalani, C. Schmults, A. Guminski +15 more
2020SKIN The Journal of Cutaneous Medicine4 citations Open access
Semantic Scholar
Impact of Prior Lines of Systemic Therapy (PST) on the Efficacy Of Cemiplimab, a Human Monoclonal Anti–PD-1, in Patients (PTS) with Advanced Cutaneous Squamous Cell Carcinoma (CSCC)
D. Rischin, N. Khushalani, C. Schmults, A. Guminski +15 more
20193 citations Open access
Semantic Scholar
Extended follow-up outcomes of patients with advanced cutaneous squamous cell carcinoma treated with cemiplimab on EMPOWER-CSCC-1: A retrospective cohort study.
Catherine Bennett, Luke S. McLean, A. Lim, M. Bressel +5 more
2025Journal of American Academy of Dermatology2 citations Open access
Semantic Scholar
Differential Mechanisms of CDKN2A (p16) Inactivation in Oral Tongue Squamous Cell Carcinomas and Correlation With Patient Outcome
A. Lim, H. Do, R. Young, Stephen Q. Wong +6 more
20142 citations
Semantic Scholar
Abstract 4693: Characterization of the differential mechanisms ofCDKN2Ainactivation in oral tongue squamous cell carcinomas and correlation with patient outcome.
A. Lim, H. Do, R. Young, Stephen Q. Wong +12 more
20132 citations
Semantic Scholar
1259 Real world experience of immunotherapy in an elderly trial-ineligible cohort of patients with advanced cutaneous squamous cell carcinoma
Luke S. McLean, A. Lim, A. Pizzolla, B. Solomon +1 more
2022Regular and Young Investigator Award Abstracts1 citations Open access
Semantic Scholar
433 A phase 2 study of evorpacept (ALX148) in combination with pembrolizumab and chemotherapy in patients with advanced head and neck squamous cell carcinoma (HNSCC); ASPEN-04
E. Cohen, K. Harrington, J. Machiels, S. Oosting +11 more
2021Journal for ImmunoTherapy of Cancer1 citations Open access
Semantic Scholar
Author Correction: Low-coverage whole-genome sequencing of extracellular vesicle-associated DNA in patients with metastatic cancer
B. Nguyen, N. Wong, T. Semple, M. Clark +6 more
2021Scientific Reports1 citations Open access
Semantic Scholar
BRAF Inhibition in BRAF V 600 E-Positive Anaplastic Thyroid Carcinoma
A. Lim, G. Taylor, A. Fellowes, Laird B Cameron +6 more
20161 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

D. Rischin×37
Invite
D. Rischin — researcher profile on SciRah
B. Solomon×15
Invite
B. Solomon — researcher profile on SciRah
M. Fury×12
Invite
M. Fury — researcher profile on SciRah
I. Lowy×11
Invite
I. Lowy — researcher profile on SciRah

×11

Invite

J. Corry — researcher profile on SciRah

A. Hauschild×10

Invite

A. Hauschild — researcher profile on SciRah

Invite

B. Hughes — researcher profile on SciRah

N. Khushalani×10

Invite

N. Khushalani — researcher profile on SciRah

Invite

R. Young — researcher profile on SciRah

Invite

M. Migden — researcher profile on SciRah

Invite

C. Schmults — researcher profile on SciRah

Invite

A. Guminski — researcher profile on SciRah